Lawood & Co’s IGC Pharma IGC Stock Holding History

Lawood & Co’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$20.2K	Hold	75,000	–	–	0.01%	94
2026 Q2	$20.4K	Hold	75,000	–	–	0.01%	95
2026 Q1	$19.7K	Hold	75,000	–	–	0.02%	90
2025 Q4	$21.1K	Buy	+75,000	New	+$26.7K	0.02%	93

Other funds holding IGC

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Lawood & Co's IGC Position: Q3 2026 in Review

Lawood & Co held its IGC Pharma (IGC) position steady in Q3 2026 at 75,000 shares worth $20.2K. The position accounts for 0.01% of the portfolio, ranked #94.

Lawood & Co first reported a position in IGC in Q4 2025 and has held it in 4 quarters since. The position peaked at $21.1K in Q4 2025. 2 funds tracked by Wall St. Rank hold IGC as of Q3 2026.

Lawood & Co held 75,000 shares of IGC Pharma worth $20.2K as of Q3 2026.
Lawood & Co left its IGC Pharma share count unchanged in Q3 2026.
IGC Pharma made up 0.01% of Lawood & Co's portfolio in Q3 2026, its #94 holding.
Lawood & Co first reported a position in IGC Pharma in Q4 2025 and has held it in 4 quarters since.
Lawood & Co's IGC Pharma position peaked at $21.1K in Q4 2025.
2 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2026.

Based on Lawood & Co's 13F filing for Q3 2026, filed 9 Oct 2026.